1. Home
  2. CBAT vs VNRX Comparison

CBAT vs VNRX Comparison

Compare CBAT & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CBAK Energy Technology Inc.

CBAT

CBAK Energy Technology Inc.

HOLD

Current Price

$0.84

Market Cap

79.2M

Sector

Miscellaneous

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.25

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBAT
VNRX
Founded
1999
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
38.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CBAT
VNRX
Price
$0.84
$0.25
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.50
AVG Volume (30 Days)
134.9K
2.1M
Earning Date
11-10-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$161,757,685.00
$1,472,007.00
Revenue This Year
$16.06
$55.98
Revenue Next Year
$70.59
$420.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.48
52 Week Low
$0.57
$0.22
52 Week High
$1.28
$0.94

Technical Indicators

Market Signals
Indicator
CBAT
VNRX
Relative Strength Index (RSI) 37.30 36.61
Support Level $0.83 $0.22
Resistance Level $0.93 $0.26
Average True Range (ATR) 0.03 0.02
MACD -0.01 0.00
Stochastic Oscillator 5.81 35.34

Price Performance

Historical Comparison
CBAT
VNRX

About CBAT CBAK Energy Technology Inc.

CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: